Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo Stock Exchange  >  Takeda Pharmaceutical Company Limited    4502   JP3463000004

TAKEDA PHARMACEUTICAL COMPANY LIMITED

(4502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations
Communiqués de presse de la société TAKEDA PHARMACEUTICAL COMPANY LIMITED
10/30TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience, Conf..
AQ
10/30TAKEDA PHARMACEUTICAL : Notice of the Revised Forecast of Consolidated Financial..
AQ
10/30Takeda Expands COVID-19 Vaccine Supply in Japan through Partnership with Mode..
AQ
10/29MORGAN STANLEY : rates CSL as Equal-weight
AQ
10/29UPDATE2 : Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021
AQ
10/29UPDATE1 : Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021
AQ
10/29URGENT : Takeda to supply 50 mil. coronavirus vaccine doses in Japan in 2021
AQ
10/29TAKEDA PHARMACEUTICAL : Urgent Headline News
AQ
10/29TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience; Conf..
BU
10/29TAKEDA PHARMACEUTICAL : FY2020 H1 Results Demonstrate Portfolio Resilience; Conf..
PU
10/29TAKEDA PHARMACEUTICAL COMPANY LIMITE : Notice of the Revised Forecast of Consoli..
EQ
10/29TAKEDA PHARMACEUTICAL : Expands COVID-19 Vaccine Supply in Japan Through Partner..
BU
10/28TAKEDA PHARMACEUTICAL : to Present Rare Bleeding Disorders Research at Thrombosi..
AQ
10/28Ono and Takeda Submit Supplemental Application for Opdivo and CABOMETYX Combi..
AQ
10/28Exelixis Announces Takeda and Ono Submit Supplemental Application for CABOMET..
AQ
10/27TAKEDA PHARMACEUTICAL : Presents Rare Bleeding Disorders Research at Thrombosis ..
BU
10/21TAKEDA PHARMACEUTICAL : BioLife Plasma Services Announces Opening of First Plasm..
BU
10/14TAKEDA PHARMACEUTICAL : Accelerates Digital Transformation with Accenture and AW..
AQ
10/13TAKEDA PHARMACEUTICAL : - Safety and Efficacy of Subcutaneous Entyvio Sustained ..
AQ
10/13TAKEDA PHARMACEUTICAL : Accelerates Digital Transformation with Accenture and AW..
AQ
10/13TAKEDA PHARMACEUTICAL : Accelerates Digital Transformation with Accenture and AW..
BU
10/12TAKEDA PHARMACEUTICAL : Safety and Efficacy of Subcutaneous Entyvio® (Vedolizuma..
BU
10/08TAKEDA PHARMACEUTICAL : First Patient Enrolled in NIH Phase 3 Trial to Evaluate ..
PU
10/08TAKEDA PHARMACEUTICAL : and Arrowhead Collaborate to Co-Develop and Co-Commercia..
PU
10/08TAKEDA PHARMACEUTICAL : and Arrowhead Collaborate to Co-Develop and Co-Commercia..
BU
09/25TAKEDA PHARMACEUTICAL : Announcement of decision on a basic plan for a merger wi..
AQ
09/24TAKEDA PHARMACEUTICAL : phRMA - Coming together to fight COVID-19, A conversatio..
AQ
09/24TAKEDA PHARMACEUTICAL : Announcement of decision on a basic plan for a merger (s..
PU
09/18FOUNDATION MEDICINE : and Takeda Announce Collaboration To Develop FoundationOne..
BU
09/18TAKEDA PHARMACEUTICAL : Presents New Data Highlighting Scientific Advancements i..
BU
09/17PODCAST : Women @ RopesTalk: Conversation With Chika Hirata, Takeda Japan
AQ
09/17TAKEDA PHARMACEUTICAL : to Divest TachoSil to Corza Health for EUR350 Million
AQ
09/16TAKEDA PHARMACEUTICAL : Opens New R&D Cell Therapy Manufacturing Facility to Sup..
AQ
09/16TAKEDA PHARMACEUTICAL : to Divest TachoSil® to Corza Health for €350 Million
BU
09/15Voyager Therapeutics Appoints Michelle Quinn Smith as Chief Human Resources O..
AQ
09/15TAKEDA PHARMACEUTICAL : Opens New R&D Cell Therapy Manufacturing Facility to Sup..
BU
09/15TAKEDA PHARMACEUTICAL : European Medicines Agency Approves Label Update for HYQV..
BU
09/11BIOLIFE PLASMA SERVICES : Announces Opening of First Plasma Collection Center in..
BU
09/10Chugai and Takeda to Join a Clinical Collaboration for Global Phase III Studi..
AQ
09/10TAKEDA PHARMACEUTICAL : Announces Results from Phase 3 Clinical Trial Evaluating..
AQ
09/09TAKEDA PHARMACEUTICAL : Announces Results from Phase 3 Clinical Trial Evaluating..
PU
09/09TAKEDA PHARMACEUTICAL : Announces Results from Phase 3 Clinical Trial Evaluating..
BU
09/09TAKEDA PHARMACEUTICAL : Divests Select Non-Core Assets in Europe to Cheplapharm ..
AQ
09/08TAKEDA PHARMACEUTICAL : Divests Select Non-Core Assets in Europe to Cheplapharm ..
BU
09/03BLACKSTONE : aims for Takeda OTC drug unit to go public within 10 yrs
AQ
09/02TAKEDA PHARMACEUTICAL : - Update on the U.S. Development Program for the Investi..
AQ
09/01TAKEDA PHARMACEUTICAL : Update on the U.S. Development Program for the Investiga..
PU
08/31MODERNA : Confirms Discussions with the Ministry of Health, Labour and Welfare t..
AQ
08/26TAKEDA PHARMACEUTICAL : Phase 2 ELEKTRA Study of Soticlestat Meets Primary Endpo..
AQ
08/26TAKEDA PHARMACEUTICAL : Phase 2 ELEKTRA Study of Soticlestat Meets Primary Endpo..
AQ
08/25Exelixis Announces Submission of Supplemental New Drug Application to U.S. Fo..
AQ
08/24TAKEDA PHARMACEUTICAL : Japan's Takeda sells drugs subsidiary to US Blackstone f..
AQ
08/24TAKEDA PHARMACEUTICAL : to Divest its Japan Consumer Health Care Business Unit t..
PU
08/24TAKEDA PHARMACEUTICAL COMPANY LIMITE : Takeda to Divest its Japan Consumer Healt..
EQ
08/24TAKEDA PHARMACEUTICAL : to Divest its Japan Consumer Health Care Business Unit t..
PU
08/18UNLIKELY TO SUCCEED : Preliminary Injunction Denied Despite Stipulation To Irrep..
AQ
08/10TAKEDA PHARMACEUTICAL : National Hemophilia Foundation and Takeda Partner with A..
BU
08/10NOVAVAX : and Takeda Announce Collaboration for Novavax COVID-19 Vaccine Candida..
AQ
08/07TAKEDA PHARMACEUTICAL : to supply Novavax's coronavirus vaccine candidate in Jap..
AQ
08/07TAKEDA PHARMACEUTICAL : Novavax and Takeda Announce Collaboration for Novavax' C..
PU
08/07TAKEDA PHARMACEUTICAL : Novavax and Takeda Announce Collaboration for Novavax' C..
PU
08/06TAKEDA PHARMACEUTICAL : BioLife Plasma Services Announces Opening of First Plasm..
BU
08/03TAKEDA PHARMACEUTICAL : Announces FY2020 Q1 Results, Confirms Management Guidanc..
AQ
08/03TAKEDA PHARMACEUTICAL : Notice of the Revised Forecast of Consolidated Financial..
AQ
08/03TAKEDA PHARMACEUTICAL : Announces Support for People Affected by 2020 Torrential..
AQ
08/03TAKEDA PHARMACEUTICAL : Announcement of a merger (simple merger/short-form merge..
PU
08/03TAKEDA PHARMACEUTICAL : Announcement of a merger (simple merger/short-form merge..
PU
08/01TAKEDA PHARMACEUTICAL : to Present Rare Bleeding Disorders Research Highlighting..
BU
07/31TAKEDA PHARMACEUTICAL : Announces U.S. FDA Breakthrough Therapy Designation Gran..
AQ
07/31TAKEDA PHARMACEUTICAL : Summary of Financial Statements for the Three-month Peri..
PU
07/31TAKEDA PHARMACEUTICAL : Announces FY2020 Q1 Results; Confirms Management Guidanc..
PU
07/31TAKEDA PHARMACEUTICAL COMPANY LIMITE : Notice of the Revised Forecast of Consoli..
EQ
07/31TAKEDA PHARMACEUTICAL : Announces Support for People Affected by 2020 Torrential..
PU
07/30TAKEDA PHARMACEUTICAL : Announces U.S. FDA Breakthrough Therapy Designation Gran..
BU
07/12TAKEDA PHARMACEUTICAL : Provides Updates on Its Pharmacokinetic-guided Prophylax..
BU
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on TAKEDA PHARMACEUTICAL COMPANY LIMITED